Solutions

Determined to make a difference for patients

Early dialogues

We use every opportunity to optimise the dialogue between all relevant stakeholders, ideally at the time of clinical development. Think about scientific technical advice meetings with the competent authorities, advisory boards with key opinion leaders and patient association groups, just to name a few.

Early Access programs

Patients in critical medical need and with a seriously debilitating or life-threatening disease can benefit in Belgium from early regulated access to a medicine, which addresses that need.

Axes Health helps in setting up a Medical Need or Compassionate Use program, according to the legal requirements.

Pricing and reimbursement

We give advice on the optimal pricing and reimbursement strategy, adapted to the local market.

We write the dossiers to request pricing and reimbursement at the local competent authorities.

We advise biopharmaceutical companies to take up a role as a healthcare partner rather than solely a product supplier. That’s why we also support our clients in working together with the healthcare professionals and patient groups in setting up services and solutions that can help patients better manage their disease and improve treatment adherence.

Innovative contracting

Managed entry agreements (MEA) allow a temporary reimbursement of innovative medicines and imply that clinical uncertainties are answered at the end of the MEA term.

Typical deliverables we offer, are a real-world data generation plan to address these clinical uncertainties, and an innovative
payment scheme to address budgetary uncertainties.

Client Stories

This is a space to promote the business, its products or its services. Use this opportunity to help site visitors become more familiar with the business and its offerings. Reach out to current and potential clients and customers to build a sense of connection and trust.